These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23019496)

  • 1. Binding of the amphetamine-like 1-phenyl-piperazine to monoamine transporters.
    Severinsen K; Kraft JF; Koldsø H; Vinberg KA; Rothman RB; Partilla JS; Wiborg O; Blough B; Schiøtt B; Sinning S
    ACS Chem Neurosci; 2012 Sep; 3(9):693-705. PubMed ID: 23019496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative modeling of the human monoamine transporters: similarities in substrate binding.
    Koldsø H; Christiansen AB; Sinning S; Schiøtt B
    ACS Chem Neurosci; 2013 Feb; 4(2):295-309. PubMed ID: 23421681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substituted methcathinones differ in transporter and receptor interactions.
    Eshleman AJ; Wolfrum KM; Hatfield MG; Johnson RA; Murphy KV; Janowsky A
    Biochem Pharmacol; 2013 Jun; 85(12):1803-15. PubMed ID: 23583454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.
    Eshleman AJ; Nagarajan S; Wolfrum KM; Reed JF; Swanson TL; Nilsen A; Janowsky A
    Psychopharmacology (Berl); 2019 Mar; 236(3):939-952. PubMed ID: 30397775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
    Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
    Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The external gate of the human and Drosophila serotonin transporters requires a basic/acidic amino acid pair for 3,4-methylenedioxymethamphetamine (MDMA) translocation and the induction of substrate efflux.
    Sealover NR; Felts B; Kuntz CP; Jarrard RE; Hockerman GH; Lamb PW; Barker EL; Henry LK
    Biochem Pharmacol; 2016 Nov; 120():46-55. PubMed ID: 27638414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
    Halberstadt AL; Brandt SD; Walther D; Baumann MH
    Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
    Guptaroy B; Fraser R; Desai A; Zhang M; Gnegy ME
    Mol Pharmacol; 2011 Mar; 79(3):520-32. PubMed ID: 21149640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for Homology Modeling of Dopamine, Norepinephrine, and Serotonin Transporters.
    Haddad Y; Heger Z; Adam V
    ACS Chem Neurosci; 2016 Nov; 7(11):1607-1613. PubMed ID: 27596073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroethoxy-1,4-diphenethylpiperidine and piperazine derivatives: Potent and selective inhibitors of [
    Hankosky ER; Joolakanti SR; Nickell JR; Janganati V; Dwoskin LP; Crooks PA
    Bioorg Med Chem Lett; 2017 Dec; 27(24):5467-5472. PubMed ID: 29153425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lobeline analogs with enhanced affinity and selectivity for plasmalemma and vesicular monoamine transporters.
    Miller DK; Crooks PA; Zheng G; Grinevich VP; Norrholm SD; Dwoskin LP
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1035-45. PubMed ID: 15121762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.
    Motel WC; Healy JR; Viard E; Pouw B; Martin K; Matsumoto RR; Coop A
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6920-6922. PubMed ID: 24211020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MS Binding Assays for the Three Monoamine Transporters Using the Triple Reuptake Inhibitor (1R,3S)-Indatraline as Native Marker.
    Grimm SH; Höfner G; Wanner KT
    ChemMedChem; 2015 Jun; 10(6):1027-39. PubMed ID: 25899387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Simulation and Mutation Studies to Elucidate Selectivity of Unsubstituted Amphetamine-like Cathinones at the Dopamine Transporter.
    Seddik A; Geerke DP; Stockner T; Holy M; Kudlacek O; Cozzi NV; Ruoho AE; Sitte HH; Ecker GF
    Mol Inform; 2017 May; 36(5-6):. PubMed ID: 27860344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Multiple MS Binding Assays for the Dopamine, Norepinephrine, and Serotonin Transporters.
    Neiens P; De Simone A; Höfner G; Wanner KT
    ChemMedChem; 2018 Mar; 13(5):453-463. PubMed ID: 29451362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD; Miller GM; Madras BK
    Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder.
    Xue W; Wang P; Tu G; Yang F; Zheng G; Li X; Li X; Chen Y; Yao X; Zhu F
    Phys Chem Chem Phys; 2018 Feb; 20(9):6606-6616. PubMed ID: 29451287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.